FastWave Medical key facts
as of Oct 2026- Developer of intravascular devices designed for the arterial to be safe, efficacious, and cost-effective.
- FastWave Medical is valued at approximately $30.0M as of Oct 2026 (last reported valuation).
- It has raised $40.0M; the latest was Early Stage VC ($19.0M) in Dec 2024.
- Notable investors include Epic Venture Partners, Grand Pharmaceutical Group, M&L Group, SCP Ventures.
- Status: Privately Held (backing).
FastWave Medical's last reported valuation, May 2022. Nothing priced has surfaced since.
- ·Watch FastWave Medical: the Monday email on marks, rounds and moves
FastWave Medical funding rounds
No funding rounds for FastWave Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs FastWave Medical
4FastWave Medical valuation
FastWave Medical's last reported valuation was $30 million in May 2022. No priced round, secondary trade or fund mark has surfaced since.
FastWave Medical investors
4 investors are on record for FastWave Medical, including Epic Venture Partners, Grand Pharmaceutical Group, M&L Group and SCP Ventures.
About FastWave Medical
Developer of intravascular devices designed for the arterial to be safe, efficacious, and cost-effective. The company offers novel, secure, and cost-effective IVL catheters engineered for crossing complex lesions and tortuous anatomy, with reliable usability and a streamlined profile, angioplasty balloons provide smooth performance, enabling medical professionals to treat patients in a mannered way.
- Sector
- Healthcare
- HQ
- Minneapolis, MN, United States
- Founded
- 2021
- Employees
- 27
- Website
- fastwavemedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.